Europe Intravenous (IV) Therapy and Vein Access Market Size, Share & Industry Trends Analysis Report By End User (Hospitals, Ambulatory Surgical Center, and Clinics), By Application, By Type, By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Europe Intravenous (IV) Therapy and Vein Access Market
Market Report Description
The Europe Intravenous (IV) Therapy and Vein Access Market would witness Market growth of 4.9% CAGR during the forecast period (2022-2028).
One of the most commonly utilized healthcare therapies is intravenous (IV) therapy. It's done in a variety of places, including emergency rooms, hospitals, clinics, nursing homes, and people's homes. IV treatment is used for a variety of purposes, including rehydrating dehydrated individuals. Dehydration can be rapid and severe in patients with acute vomiting and/or diarrhea, especially in children. IV treatment replaces and transfers fluids and electrolytes, giving the digestive system a break.
The IV therapy and vein access Market 's manufacturers and players offer a wide range of essential solutions and products, including double and single lumen implantable ports, peripheral intravenous catheters, peripherally inserted central catheters, central intravenous catheters, infusion pumps, and hypodermic needles, among others. Volume expanders, blood-based products, nutrition and buffer solutions, and drug delivery are just a few of the applications for which these goods and solutions are used in the medical and healthcare industries. Clinics, ambulatory surgery centres, and hospitals are among the top end users for IV therapy and vein access products and solutions in the regional Market .
There has been an increase in the prevalence of various chronic diseases that require vascular access treatment over the previous decade. Cancer, kidney failure, and heart disease, among other chronic diseases, as well as various lifestyle conditions like hypertension, obesity, diabetes, and depression, among others, necessitate critical care during hospitalization. The increase in such chronic diseases would boost the growth of the Market in the upcoming years.
The regional Market is growing due to a rise in the number of approved IV medications that are utilized for therapy. The Artesunate injectable, for example, was approved by the Food and Drug Administration (FDA) in June 2020 for the treatment of malaria, according to the New England Journal of Medicine (NEJM). The intravenous (IV) therapy and vein access device devices in Europe are very competitive. This region is home to a number of prominent medical equipment companies. In hospitals across Europe, intravenous (IV) therapy and vein access devices are widely employed.
As per the World Health Organization (WHO), the global burden of chronic diseases is rapidly increasing. Chronic diseases accounted for nearly 60% of the world's 56.5 million total fatalities and 46% of the global burden of disease in 2001, and this figure is anticipated to rise to 57 percent by 2020. Individuals with chronic diseases also receive just 56% of recommended preventative health care treatments, as per the New England Journal of Medicine. Some of the growth factors for the regional Market are an increase in the elderly population, a rise in the frequency of chronic diseases, and an increase in the usage of portable infusion pumps. Therefore, these aspects are expected to fuel the growth of the regional Intravenous (IV) Therapy and Vein Access Market over the forecast years.
The Germany Market dominated the Europe Intravenous (IV) Therapy and Vein Access Market by Country 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $2,152.4 million by 2028,. The UK Market is expected to witness a CAGR of 4% during (2022 - 2028). Additionally, The France Market would showcase a CAGR of 5.6% during (2022 - 2028).
Based on End User, the Market is segmented into Hospitals, Ambulatory Surgical Center, and Clinics. Based on Application, the Market is segmented into Medication Administration, Blood Based Products, Nutrition & Buffer Solution, and Volume Expander. Based on Type, the Market is segmented into Intravenous Catheters, Infusion Pumps, Hypodermic Needles, Implantable Ports, and Others. Based on countries, the Market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include B. Braun Melsungen AG, Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc., Smiths Group PLC, and AngioDynamics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Ambulatory Surgical Center
- Medication Administration
- Blood Based Products
- Nutrition & Buffer Solution
- Volume Expander
- Intravenous Catheters
- Infusion Pumps
- Hypodermic Needles
- Implantable Ports
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- B. Braun Melsungen AG
- Medtronic PLC
- Terumo Corporation
- Fresenius SE & Co. KGaA
- Cardinal Health, Inc.
- Pfizer, Inc.
- Teleflex, Inc.
- Baxter International, Inc.
- Smiths Group PLC
- AngioDynamics, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free